{"id":35058,"date":"2020-09-25T10:30:33","date_gmt":"2020-09-25T10:30:33","guid":{"rendered":"https:\/\/biomedpharmajournal.org\/?p=35058"},"modified":"2020-11-04T09:21:09","modified_gmt":"2020-11-04T09:21:09","slug":"description-of-confirmed-cases-and-deaths-from-covid-19-in-mexico-until-may-6-2020-an-ecological-study","status":"publish","type":"post","link":"https:\/\/biomedpharmajournal.org\/staging\/vol13no3\/description-of-confirmed-cases-and-deaths-from-covid-19-in-mexico-until-may-6-2020-an-ecological-study\/","title":{"rendered":"Description of Confirmed Cases and Deaths from COVID-19 in Mexico, Until May 6, 2020: an Ecological Study"},"content":{"rendered":"

Introduction<\/strong><\/p>\n

As of December 8, 2019, several cases of pneumonia of unknown cause have been reported in Wuhan, Hubei Province, China1-3<\/sup> most of the patients worked in or lived around the Huanan seafood market, where animals for sale also live4<\/sup>. On December 31, 2019, a case of pneumonia of unknown cause was reported at the World Health Organization (WHO) office in Whuan, China5<\/sup>.<\/p>\n

On January 10, 2020, the first death reported in China occurs from this new infection and on January 13, 2020, the first case was reported outside of China, in Thailand6<\/sup>. The outbreak is declared a Public Health emergency of international interest on January 30, 20205<\/sup>.<\/p>\n

Idiopathic pneumonia is reported to be caused by a new coronavirus on February 7 and the WHO named it 2019-nCoV7<\/sup>. The new disease caused by coronavirus was named COVID-19 on February 11, 20205<\/sup>.<\/p>\n

After a month, the virus was isolated, its genome was sequenced and its morphology was described; on January 12, 2020, the virus genome was shared with WHO by the Chinese Center for Disease Control and Prevention8<\/sup>. Zhou et al,9<\/sup> reported that the causer of COVID-19 shares 79.5% of the SARS-CoV sequence; also, it uses the same cell entry receptor, angiotensin-converting enzyme-2, as SARS-CoV.<\/p>\n

Zhu e t al.10<\/sup>, reported the cytopathic effects and morphology and it is a member of a family of coronaviruses that infect humans; grew more in human airway epithelial cells than tissue culture cells, suggesting the potential for increased infectivity.<\/p>\n

In Mexico, the follow-up of cases begins at the end of January, by February 20, 2020 the first confirmed case was reported and by March 23, 405 cases had been confirmed in the country11<\/sup> and by 28 of the same month 848 cases had been confirmed12<\/sup>. All cases at the beginning traveled to United States of America, Spain or Italy, no one traveled to China11<\/sup>.<\/p>\n

The objective is to describe the confirmed cases of COVID-10 as well as the mortality due to COVID-19 in the Mexican population.<\/p>\n

Material and Methods<\/strong><\/p>\n

A descriptive ecological study was designed with public data on confirmed, suspected and deceased cases by COVID-19 from the General Directorate of Epidemiology and the National System of Epidemiological Surveillance of the Ministry of Health of Mexico13<\/sup>.<\/p>\n

Data on age, gender, state of residence, date of onset of symptoms, date of death were collected if it occurred. The date of positive test is missing in database.<\/p>\n

For the statistical analysis, frequencies and percentages of categorical variables and mean and standard deviation were used for quantitative variables.<\/p>\n

The STATA \u00ae 13.0 program (Stata Corp., College Station, TX, USA) was used.<\/p>\n

Results<\/strong><\/p>\n

Public records of confirmed cases of SARS-CoV-2 infection giving COVID-19 were 27,634 records.<\/p>\n

Age range from 0 to 113 years with a mean of 46.72 \u00b1 15.62 years. Table 1 shows the distribution by gender and by state reported by confirmed cases.<\/p>\n

Table 1: Confirmed cases by gender and residence state (n=27,634)<\/strong><\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Variable<\/strong><\/td>\nn<\/strong><\/td>\n%<\/strong><\/td>\n<\/tr>\n
Gender<\/strong><\/p>\n

Female<\/p>\n

Male<\/td>\n

 <\/p>\n

11,475<\/p>\n

16,159<\/td>\n

 <\/p>\n

41.52<\/p>\n

58.48<\/td>\n<\/tr>\n

States<\/strong><\/td>\n<\/td>\n<\/td>\n<\/tr>\n
\u00a0\u00a0 Aguascalientes<\/td>\n292<\/td>\n1.06<\/td>\n<\/tr>\n
\u00a0\u00a0 Baja California<\/td>\n2,097<\/td>\n7.59<\/td>\n<\/tr>\n
\u00a0\u00a0 Baja California Sur<\/td>\n358<\/td>\n1.30<\/td>\n<\/tr>\n
\u00a0\u00a0 Campeche<\/td>\n147<\/td>\n0.53<\/td>\n<\/tr>\n
\u00a0\u00a0 Coahuila de Zaragoza<\/td>\n491<\/td>\n1.78<\/td>\n<\/tr>\n
\u00a0\u00a0 Colima<\/td>\n31<\/td>\n0.11<\/td>\n<\/tr>\n
\u00a0\u00a0 Chiapas<\/td>\n263<\/td>\n0.95<\/td>\n<\/tr>\n
\u00a0\u00a0 Chihuahua<\/td>\n600<\/td>\n2.17<\/td>\n<\/tr>\n
\u00a0\u00a0 Cd Mexico<\/td>\n7,521<\/td>\n27.22<\/td>\n<\/tr>\n
\u00a0\u00a0 Durango<\/td>\n91<\/td>\n0.33<\/td>\n<\/tr>\n
\u00a0\u00a0 Guanajuato<\/td>\n343<\/td>\n1.24<\/td>\n<\/tr>\n
\u00a0\u00a0 Guerrero<\/td>\n413<\/td>\n1.49<\/td>\n<\/tr>\n
\u00a0\u00a0 Hidalgo<\/td>\n396<\/td>\n1.43<\/td>\n<\/tr>\n
\u00a0\u00a0 Jalisco<\/td>\n492<\/td>\n1.78<\/td>\n<\/tr>\n
\u00a0\u00a0 Mexican State<\/td>\n4,661<\/td>\n16.87<\/td>\n<\/tr>\n
\u00a0\u00a0 Michoac\u00e1n de Ocampo<\/td>\n423<\/td>\n1.53<\/td>\n<\/tr>\n
\u00a0\u00a0 Morelos<\/td>\n612<\/td>\n2.21<\/td>\n<\/tr>\n
\u00a0\u00a0 Nayarit<\/td>\n151<\/td>\n0.55<\/td>\n<\/tr>\n
\u00a0\u00a0 Nuevo Le\u00f3n<\/td>\n511<\/td>\n1.85<\/td>\n<\/tr>\n
\u00a0\u00a0 Oaxaca<\/td>\n202<\/td>\n0.73<\/td>\n<\/tr>\n
\u00a0\u00a0 Puebla<\/td>\n910<\/td>\n3.29<\/td>\n<\/tr>\n
\u00a0\u00a0 Quer\u00e9taro<\/td>\n179<\/td>\n0.65<\/td>\n<\/tr>\n
\u00a0\u00a0 Quintana Roo<\/td>\n980<\/td>\n3.55<\/td>\n<\/tr>\n
\u00a0\u00a0 San Luis Potos\u00ed<\/td>\n187<\/td>\n0.68<\/td>\n<\/tr>\n
\u00a0\u00a0 Sinaloa<\/td>\n1,248<\/td>\n4.52<\/td>\n<\/tr>\n
\u00a0\u00a0 Sonora<\/td>\n342<\/td>\n1.24<\/td>\n<\/tr>\n
\u00a0\u00a0 Tabasco<\/td>\n1,319<\/td>\n4.77<\/td>\n<\/tr>\n
\u00a0\u00a0 Tamaulipas<\/td>\n415<\/td>\n1.50<\/td>\n<\/tr>\n
\u00a0\u00a0 Tlaxcala<\/td>\n280<\/td>\n1.01<\/td>\n<\/tr>\n
\u00a0\u00a0 Veracruz Ignacio de la\u00a0\u00a0 Llave<\/td>\n872<\/td>\n3.16<\/td>\n<\/tr>\n
\u00a0\u00a0 Yucat\u00e1n<\/td>\n688<\/td>\n2.49<\/td>\n<\/tr>\n
\u00a0\u00a0 Zacatecas<\/td>\n119<\/td>\n0.43<\/td>\n<\/tr>\n
Total<\/td>\n27,634<\/td>\n100.0<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

Source: Secretary of Health [13]\n

Figure 1 shows the map of Mexico with names of the states.<\/p>\n\n\n\n
\"Figure<\/td>\nFigure 1: Map of Mexico<\/strong><\/p>\n

Click her to view figure<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

By May 6, 2020, 27,634 confirmed cases had been reported, higher than 848 cases reported on March 28, 2020, corresponding on average to an increase of 83.56% cases per day in that period. Despite noticing a decrease in confirmed cases in the first days of May 2020, it is considered an artifact due to the delay in delivering the results of the Real Time-PCR test.<\/p>\n

Figure 2 shows the curve of accumulated cases as of May 6, 2020.<\/p>\n\n\n\n
\"Figure<\/td>\nFigure 2: Distribution of confirmed cases by day (n=27,634)[13]<\/strong><\/p>\n

Click here to view figure<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

Source: Secretary of Health [13]\n

Figure 3 shows the deaths reported by COVID-19 per day. On March 28, 200, a specific mortality rate of 1.9% was reported, with 16 deaths among 848 confirmed cases. For May 6, 2020, the specific mortality rate was 9.8% with 2704 deaths among 27,634 confirmed cases.<\/p>\n\n\n\n
\"Figure<\/td>\nFigure 3: Distribution of deaths by day (n=2,704)[13]<\/strong><\/p>\n

Click here to view figure<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

Source: Secretary of Health [13]\n

Discussion<\/strong><\/p>\n

Of the 27,634 confirmed cases in Mexico as of May 6, 2020, men predominated slightly with 58.38% and the states with the highest frequency were: Mexico City (27.22%), State of Mexico (16.87%), Baja California (7.59% ), Tabasco (4.77%) and Sinaloa (4.52%) (Table 1).<\/p>\n

In the public data of the General Directorate of Epidemiology, of the National Epidemiological Surveillance System of the Ministry of Health of Mexico, on March 23, 202014<\/sup>, the first confirmed case started with symptoms on February 20, 2020; in the database of May 6, 202013<\/sup>, several cases with symptom onset were reported on January 8, 14, 15 and 17, 2020. One reason is the delay in the result of the RT-PCR tests. Each state health system must report each case to the federal health system.<\/p>\n

In mid-March, some state governments such as Guanajuato, Jalisco, among others, began to restrict the meetings of more than 10 people, cancel massive events, and by March 23, social isolation measures had been implemented and school activities were suspended at all levels, with the aim of reducing community transmission of SARS-CoV-2.<\/p>\n

Sanche et al.15<\/sup>, they estimated a serial interval of 6 to 9 days and calculated R0 of 5.7, so they recommended active surveillance, contact surveillance, quarantine and strong social distancing to stop the transmission of the virus. If one case can infect almost six more people, the spread of the infection will continue to appear in the community. Quarantine and social isolation aim to decrease this Ro.<\/p>\n

Analyzing the confirmed cases from March 23 to May 6, 2020 in Mexico, it is found that there was an increase in cases from 405 to 27,634, in 43 days, with an average of 158.67% per day of increase in cases per day, much higher than Italy and to Spain with an average and increase in confirmed cases of 25 and 20%, respectively16<\/sup>.<\/p>\n

Bulut et al.17<\/sup>, report that accord to early models total 10-12 weeks is required to control an outbreak in the community, but in all countries affected by COVID-19 is needed more than 12 week to flatted the epi.curve of new cases.<\/p>\n

Matrajt et al.18<\/sup>, reported that after social distancing interventions, 20% of new cases and most hospitalizations were averted, but to the end of intervention, the epidemic rebounded. Similar conclusion reported by Li et al.19<\/sup>, imposing social controls impact the number of new cases.<\/p>\n

Regarding mortality, Mexico reported 5 deaths on March 2420<\/sup>, and for May 6, 2020, the registered deaths were 2,704, with an average daily increase of 1.257% in specific mortality. The specific mortality rate for Mexico, as of May 6, 2020, was 9.8% higher than that reported by the PAHO on the same day of 7.11%21<\/sup>.<\/p>\n

With the figures of confirmed cases and deaths in Mexico, they confirm that the social isolation and the quarantine established by the health authorities have not produced a decrease in new cases. The massive campaigns launched targeting the general population, to stay home, wear protection (face masks) and wash your hands have not produced the expected results.<\/p>\n

Conclusi\u00f3n<\/strong><\/p>\n

Although quarantine and social isolation were implemented more than a month ago, the number of confirmed cases in Mexico continues to grow. Social isolation measures and a healthy distance between people must be reinforced.<\/p>\n

Conflict of interest<\/strong><\/p>\n

Nothing to declare<\/p>\n

Funding source<\/strong><\/p>\n

No one<\/p>\n

References<\/strong><\/p>\n

    \n
  1. \u00a0Lu H, Stratton CW, Tang YW. Outbreak of pneumonia of unknown etiology in Wuhan, China: the mystery and the miracle. J Med Virol. 2020;92(4):401-402.\u00a0 Doi: https:\/\/doi.org\/10.1002\/jmv.25678<\/li>\n
  2. Hui DS, Azhar EI, Madani TA, Ntoumi F, Kock R, Dar O,\u00a0 et al. The continuing 2019-nCoV epidemic threatof novel coronaviruses to global health \u2013 the latest 2019 novel coronavirus outbreak in Wuhan, China. Int J Infect Dis. 2020; 91: 264-66 Doi: https:\/\/doi.org\/10.1016\/j.ijid.2020.01.009<\/li>\n
  3. Huang C, Wang Y, Li X, Ren L, Zhao J, Yi\u00a0 Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 2020;395(10223):497-506\u00a0\u00a0\u00a0 Doi: https:\/\/doi.org\/10.1016\/S0140-6736(20)30183-5<\/li>\n
  4. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet. 2020;395(10223):507-13\u00a0\u00a0\u00a0\u00a0\u00a0 https:\/\/doi.org\/10.1016\/S0140-6736(20)30211-7<\/li>\n
  5. World Health Organization. Rolling updates on coronavirus disease (COVID-19). Updated 7 May 2020. Available in: https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019\/events-as-they-happen<\/li>\n
  6. Yoo JH, Hong ST. The outbreak caseswith the novel coronavirus suggest upgraded quarantine and isolation in Korea. J Korean Med Sci. 2020;35(5): e62 Doi: https:\/\/doi.org\/10.3346\/jkms.2020.35.e62<\/li>\n
  7. Carlos WG, Dela Cruz C, Cao B, Pasnick S, Jamil S, Novel Wuhan (2019-CoV) coronavirus. Am J Respi Crit Care Med 2020;201(4):7-8 Doi: https:\/\/doi.org\/10.1164\/rccm.2014P7<\/li>\n
  8. Zhang Y, Ku J, Li H, Cao B. A novel coronavirus (COVID-19) outbreak. A call for action. Chest. 2020;157(4):e99-e101. Doi: https:\/\/doi.org\/10.1016\/j.chest.2020.02.014<\/li>\n
  9. Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579:270-3.\u00a0\u00a0\u00a0\u00a0 https:\/\/doi.org\/10.1038\/s41586-020-2012-7<\/li>\n
  10. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020; 382:727:37. Doi: https:\/\/doi.org\/10.1056\/NEJMoa2001017<\/li>\n
  11. National System of Surveillance Epidemiological. General Directorate of Epidemiology. Secretary of Health. Confirmed cases to disease by COVID-19. 2020. Available in: https:\/\/www.gob.mx\/cms\/uploads\/attachment\/file\/543205\/Tabla_casos_positivos_COVID-19_resultado_InDRE_2020.03.24.pdf<\/li>\n
  12. National System of Surveillance Epidemiological. General Directorate of Epidemiology. Secretary of Health. Confirmed cases to disease by COVID-19. 2020. Available in: https:\/\/www.gob.mx\/cms\/uploads\/attachment\/file\/544029\/Tabla_casos_positivos_COVID-19_resultado_InDRE_2020.03.28.pdf<\/li>\n
  13. Secretary of Health. Open data. Historic databases. May 6, 2020. Availablein:\u00a0https:\/\/www.gob.mx\/salud\/documentos\/datos-abiertos-bases-historicas-direccion-general-de-epidemiologia<\/li>\n
  14. National System of Surveillance Epidemiological. General Directorate of Epidemiology. Secretary of Health. Confirmed cases to disease by COVID-19. 2020. Available in: https:\/\/www.gob.mx\/cms\/uploads\/attachment\/file\/543205\/Tabla_casos_positivos_COVID-19_resultado_InDRE_2020.03.24.pdf<\/li>\n
  15. Sanche S, Lin YT, Romero-Severson E, Hengartner N,\u00a0 Ke R. High Contagiousness and Rapid Spread of Severe Acute Respiratory Syndrome Coronavirus 2. Emerg Infect Dis. 2020; 26(7): 1470-1477. Doi: https:\/\/doi.org\/10.3201\/eid2607.200282<\/li>\n
  16. Cordova-Lepe F, Guti\u00e9rrez-Aguilar R, Guti\u00e9rrez-Jara JP. Number of COVID-19 cases in Italia at 120 days with data at 21\/03\/2020 and threshold of daily effort to flatten the epi-curve. Medwave 2020;20(2):e7861 Doi: http:\/\/doi.org\/10.5867\/medwave.2020.02.7861<\/li>\n
  17. Bulut C, Kato Y. Epidemiology of COVID-19 Turk J Med Sci. 2020;50(S1-1): 563-570. Doi: http:\/\/doi.org\/10.3906\/sag-2003-172<\/li>\n
  18. Matrajt L, Leung T. Evaluating the effectiveness of social distancing interventions to delay or flatten the epidemic curve of Coronavirus disease. Emerg. Infect. Dis. 2020; 26(8). Doi: http:\/\/doi.org\/10.3201\/eid2608.201093<\/li>\n
  19. Li L, Yang Z, Dang Z, Meng C, Huang J, Meng H, et al. Propagation analysis and prediction of the COVID-19. Infectious Disease Modelling. 2020; 3: 282-292. Doi: http:\/\/doi.org\/10.1016\/j.idm.2020.03.002<\/li>\n
  20. Unidad de Inteligencia Epidemiol\u00f3gica y Sanitaria. Secretar\u00eda de Salud. Comunicado t\u00e9cnico diario nuevo Coronavirus en el Mundo (COVID-19). 2020. Cited: March 25, 2020. Available in: https:\/\/www.gob.mx\/cms\/uploads\/attachment\/file\/543207\/Comunicado_Tecnico_Diario_COVID-19_2020.03.24.pdf<\/li>\n
  21. PanAmerican Health Organization.\u00a0 COVID-19. Novel coronavirus 2019. Updated 6 May 2020. Available in: https:\/\/www.paho.org\/arg\/index.php?option=com_docman&view=download&alias=489-actualizacion-covid-19-6-de-mayo-de-2020&category_slug=actualizaciones&Itemid=624<\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"

    Introduction As of December 8, 2019, several cases of pneumonia […]<\/p>\n","protected":false},"author":14,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[79],"tags":[],"class_list":["post-35058","post","type-post","status-publish","format-standard","hentry","category-vol13no3"],"_links":{"self":[{"href":"https:\/\/biomedpharmajournal.org\/staging\/wp-json\/wp\/v2\/posts\/35058","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/biomedpharmajournal.org\/staging\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/biomedpharmajournal.org\/staging\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/biomedpharmajournal.org\/staging\/wp-json\/wp\/v2\/users\/14"}],"replies":[{"embeddable":true,"href":"https:\/\/biomedpharmajournal.org\/staging\/wp-json\/wp\/v2\/comments?post=35058"}],"version-history":[{"count":6,"href":"https:\/\/biomedpharmajournal.org\/staging\/wp-json\/wp\/v2\/posts\/35058\/revisions"}],"predecessor-version":[{"id":36670,"href":"https:\/\/biomedpharmajournal.org\/staging\/wp-json\/wp\/v2\/posts\/35058\/revisions\/36670"}],"wp:attachment":[{"href":"https:\/\/biomedpharmajournal.org\/staging\/wp-json\/wp\/v2\/media?parent=35058"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/biomedpharmajournal.org\/staging\/wp-json\/wp\/v2\/categories?post=35058"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/biomedpharmajournal.org\/staging\/wp-json\/wp\/v2\/tags?post=35058"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}